Aristotle University Of Thessaloniki (AUTH)
Mechanistic characterization of MSC1-mediated tumor suppression in colorectal cancer: an integrative systems biology and experimental approach
Abstract
dc:descriptionMesenchymal stem cells (MSCs) are promising candidates for cell-based cancer therapies due to their immunomodulatory properties, tumor-homing capacity, and low immunogenicity, yet their role in colorectal cancer (CRC) remains controversial. The mesenchymal stem cells type 1 (MSC1) phenotype, a pro-inflammatory and tumor-suppressive state of MSCs induced by short-term and low-dose lipopolysaccharide (LPS) activation via Toll-like Receptor 4 (TLR4), has emerged as a promising therapeutic model, but is poorly characterized, and its effects in CRC are unexplored. In this study, the tumor-suppressive mechanisms of MSC1 were mapped and their effects on CRC were evaluated using integrated bioinformatics and in vitro approaches. A high-confidence protein-protein interaction network (PPI) downstream of TLR4 activation in Wharton’s jelly-derived MSCs (WJ-MSCs) was constructed, through which key enriched signaling pathways, transcriptional regulators, and a novel anti-cancer secretome were revealed. Functional and transcriptional enrichment analyses identified six key tumor-suppressive mechanisms of MSC1: (i) metabolic reprogramming via enhanced glucose and lipid uptake, phosphoinositide signaling, and membrane/protein recycling, (ii) enhanced antioxidant defenses, including Son of Sevenless (SOS) signaling and the cystine/glutamate antiporter (system xc⁻), (iii) extracellular matrix (ECM) stabilization and laminin-111–integrin–mediated adhesion and migration, (iv) anti-cancer secretome with direct inhibitory effects, (v) regulation of cell survival and inhibition of transformation into a more tumor-permissive phenotype via balanced proliferation, apoptosis, and epigenetic signaling, and (vi) controlled pro-inflammatory signaling with anti-inflammatory feedback. Additionally, migration- and adhesion-related interaction sequences in laminin-111 were identified as being targeted by cAMP-dependent Protein Kinase A (PKA), Protein Kinase C (PKC), and Casein Kinase 2 (CKII) through experimentally observed and predicted phosphorylation events. MSC1 function in CRC was validated using in vitro co-cultures with CRC cell lines. Significant suppression of cancer cell proliferation and metabolism was demonstrated, providing the first experimental evidence of a tumor-suppressive role for MSC1 in this context. These findings elucidate the mechanisms of MSC1 in CRC and establish a foundation for the development of MSC1-based therapies.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2026
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Galliou, Panagiota-Angeliki
- Γάλλιου, Παναγιώτα-Αγγελική
Subjects
dc:subject × 32- Πόλωση μεσεγχυματικών βλαστικών κυττάρων τύπου 1 (MSC1)
- Μεσεγχυματικά βλαστικά κύτταρα (MSCs)
- Καρκίνος του παχέος εντέρου (CRC)
- Ογκοκαταστολή
- Μεταβολικός επαναπρογραμματισμός
- Λιποπολυσακχαρίτης (LPS)
- Σηματοδότηση μέσω TLR4
- Λαμινίνη-111
- Σηματοδότηση κινασών (PKA, PKC, CKII)
- Μηχανιστικός χαρακτηρισμός
- Μικροπεριβάλλον όγκου (TME)
- Συστημική βιολογία
- Δίκτυα αλληλεπίδρασης πρωτεϊνών
- Mesenchymal Stem Cells Type 1 (MSC1) Polarization
- Mesenchymal Stem Cells (MSCs)
- Colorectal cancer (CRC)
- Tumor suppression
- Metabolic reprogramming
- Lipopolysaccharide (LPS)
- TLR4 signaling
- Laminin-111
- Kinase signaling (PKA, PKC, CKII)
- Mechanistic characterization
- Tumor microenvironment (TME)
- Systems biology
- Protein–Protein Interaction Networks
- Βασική Ιατρική
- Ιατρική και Επιστήμες Υγείας
- Ιατρική βιοχημεία
- Basic Medicine
- Medical and Health Sciences
- Medical Biochemistry
Rights
- Language dc:language
- eng
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/60902